NANOBIOTIX SA - ADR

$8.98 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About NANOBIOTIX SA - ADR

Nanobiotix operates as a late clinical-stage nanomedicine company. The Company offers oncology nanomedicine treatments to control and treat cancer tumors. Nanobiotix serves customers in the United States and France.

Stock Analysis

last close -
1-mo return -
3-mo return -
avg daily vol. -
52-week high -
52-week low -
market cap. -
forward pe -
annual div. -
roe -
ltg forecast -
dividend yield -
annual rev. -
inst own. -
baraka

Subscribe now for daily local and international financial news

Subscribe